Eli Lilly And Stock Market Value
| LLY Stock | USD 745.95 4.82 0.64% |
| Symbol | Eli |
Eli Lilly Price To Book Ratio
Is Eli Lilly's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eli Lilly. If investors know Eli will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eli Lilly listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.13 | Dividend Share 4.52 | Earnings Share 5.78 | Revenue Per Share 37.908 | Quarterly Revenue Growth 0.281 |
The market value of Eli Lilly is measured differently than its book value, which is the value of Eli that is recorded on the company's balance sheet. Investors also form their own opinion of Eli Lilly's value that differs from its market value or its book value, called intrinsic value, which is Eli Lilly's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eli Lilly's market value can be influenced by many factors that don't directly affect Eli Lilly's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Eli Lilly's value and its price as these two are different measures arrived at by different means. Investors typically determine if Eli Lilly is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eli Lilly's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Eli Lilly 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Eli Lilly's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Eli Lilly.
| 04/25/2023 |
| 04/19/2024 |
If you would invest 0.00 in Eli Lilly on April 25, 2023 and sell it all today you would earn a total of 0.00 from holding Eli Lilly and or generate 0.0% return on investment in Eli Lilly over 360 days. Eli Lilly is related to or competes with Alkermes Plc, Ironwood Pharmaceuticals, Deciphera Pharmaceuticals, Eagle Pharmaceuticals, Neurocrine Biosciences, and Dynavax Technologies. Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide More
Eli Lilly Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Eli Lilly's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Eli Lilly and upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.44 | |||
| Information Ratio | 0.1193 | |||
| Maximum Drawdown | 9.42 | |||
| Value At Risk | (2.31) | |||
| Potential Upside | 3.18 |
Eli Lilly Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Eli Lilly's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Eli Lilly's standard deviation. In reality, there are many statistical measures that can use Eli Lilly historical prices to predict the future Eli Lilly's volatility.| Risk Adjusted Performance | 0.1062 | |||
| Jensen Alpha | 0.2088 | |||
| Total Risk Alpha | 0.098 | |||
| Sortino Ratio | 0.1333 | |||
| Treynor Ratio | 0.3508 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Eli Lilly's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Eli Lilly Backtested Returns
Eli Lilly appears to be very steady, given 3 months investment horizon. Eli Lilly secures Sharpe Ratio (or Efficiency) of 0.17, which denotes the company had a 0.17% return per unit of risk over the last 3 months. We have found thirty technical indicators for Eli Lilly and, which you can use to evaluate the volatility of the firm. Please utilize Eli Lilly's Coefficient Of Variation of 617.59, downside deviation of 1.44, and Mean Deviation of 1.14 to check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Eli Lilly holds a performance score of 13. The firm shows a Beta (market volatility) of 0.71, which means possible diversification benefits within a given portfolio. As returns on the market increase, Eli Lilly's returns are expected to increase less than the market. However, during the bear market, the loss of holding Eli Lilly is expected to be smaller as well. Please check Eli Lilly's treynor ratio, as well as the relationship between the expected short fall and day median price , to make a quick decision on whether Eli Lilly's price patterns will revert.
Auto-correlation | 0.92 |
Excellent predictability
Eli Lilly and has excellent predictability. Overlapping area represents the amount of predictability between Eli Lilly time series from 25th of April 2023 to 22nd of October 2023 and 22nd of October 2023 to 19th of April 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Eli Lilly price movement. The serial correlation of 0.92 indicates that approximately 92.0% of current Eli Lilly price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.92 | |
| Spearman Rank Test | 0.83 | |
| Residual Average | 0.0 | |
| Price Variance | 6842.82 |
Eli Lilly lagged returns against current returns
Autocorrelation, which is Eli Lilly stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Eli Lilly's stock expected returns. We can calculate the autocorrelation of Eli Lilly returns to help us make a trade decision. For example, suppose you find that Eli Lilly has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Eli Lilly regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Eli Lilly stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Eli Lilly stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Eli Lilly stock over time.
Current vs Lagged Prices |
| Timeline |
Eli Lilly Lagged Returns
When evaluating Eli Lilly's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Eli Lilly stock have on its future price. Eli Lilly autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Eli Lilly autocorrelation shows the relationship between Eli Lilly stock current value and its past values and can show if there is a momentum factor associated with investing in Eli Lilly and.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Eli Lilly Correlation, Eli Lilly Volatility and Eli Lilly Alpha and Beta module to complement your research on Eli Lilly. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Complementary Tools for Eli Stock analysis
When running Eli Lilly's price analysis, check to measure Eli Lilly's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eli Lilly is operating at the current time. Most of Eli Lilly's value examination focuses on studying past and present price action to predict the probability of Eli Lilly's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eli Lilly's price. Additionally, you may evaluate how the addition of Eli Lilly to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |
Eli Lilly technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.